Efficacy of Metformin in Lean Women With Polycystic Ovary Syndrome
Not Applicable
- Conditions
- Polycystic Ovary Syndrome
- Registration Number
- NCT00319293
- Lead Sponsor
- Aarhus University Hospital Skejby
- Brief Summary
Insulin resistance is an important feature of the polycystic ovary syndrome,and patiens are successfully treated with the insulin sensitizing agent metformin. The insulin resistance of lean patients with the syndrome is debated. In this study, we will study the change in insulin resistance, metabolic and hormonal factors after 3 months of metformin treatment in lean PCOS women.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 20
Inclusion Criteria
- PCOS (Rotterdam criteria)
- BMI < 27
- No medication for 3 months
Exclusion Criteria
- Pregnancy
- Lactation
- Other endocrinologic disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Insulin resistance Hormonal factors Metabolic factors
- Secondary Outcome Measures
Name Time Method